Small Brand, Regulated Category

Supplements is a category where scale confers real advantages, and small brands frequently tell a flattering story about being small that doesn't survive scrutiny.

Here's a more honest sort.

What scale genuinely buys

Starting here, because pretending otherwise would be silly.

Unit cost. Ingredient purchasing at volume, dedicated high-throughput lines, amortised equipment and tooling. A large manufacturer's cost per unit is a fraction of a small one's.

Analytical capacity. This one matters more than people realise in a regulated category. In-house laboratories, method development, stability chambers, dedicated quality personnel. A small company buys those services; a large one has them down the hall.

Regulatory capacity. Product licensing, site licensing, GMP documentation and adverse reaction systems all carry substantial fixed costs. Compliance is far cheaper per unit at scale.

Distribution and shelf position. Retail space is allocated commercially. The ability to fund placement and promotion is a genuine advantage.

The two real advantages of being small

1. Formulating without a volume constraint

A global manufacturer formulating a product has to work with ingredients available at enormous scale, at stable prices, from multiple qualified suppliers.

That favours conventional inputs. Gelatin rather than pectin. Sugar rather than a polyol-plus-stevia system. Standard depositing and curing parameters rather than a process tuned around a degradation-prone active.

Choosing pectin costs formulation effort and produces a different texture. Removing sugar makes flavour masking harder for an active that has a flavour. Tuning pH, temperature and curing around creatine stability rather than around throughput costs process time.

Those are all trades a small operation can make and a category leader mostly can't justify at national volume. See flavour development without sugar.

2. Being answerable in a single conversation

The practical one, and it's the advantage we lean on hardest.

When someone emails asking for a certificate of analysis, or a kosher certificate, or which lot their pouch came from, that question reaches someone who can answer it — not a contact centre routing to a form.

Several posts on this blog direct people to hello@flexfoods.ca precisely because that's answerable. It's a genuine advantage of scale in reverse, and it's also an obligation — a transparency position that fails when tested is worse than saying nothing. See why we publish our limitations.

Three claims small brands make that we'd be sceptical of

"Higher quality ingredients." Sometimes true, frequently not. Large manufacturers have sophisticated quality systems and enormous reputational exposure. Ingredient quality is determined by specification and supplier qualification, not by company size.

For creatine specifically this matters little either way: monohydrate is produced by chemical synthesis at a small number of global facilities. Almost everyone is buying from the same handful of sources. See monohydrate vs other forms.

"More care." Pleasant to believe, hard to substantiate. What makes products safe and consistent is documented process control, and large facilities frequently have better documentation than small ones.

"More rigorous testing." Often the reverse, and it's the claim most worth interrogating in this category. Analytical capacity is expensive. A small company may test less frequently than a large one simply because each test costs more relative to a batch.

Which means asking a small brand for testing data is a more searching question than asking a large one — and it's the question that matters most for a creatine gummy. See how to check a creatine gummy.

What the regulated category changes

Being in an NHP category rather than a food one alters the picture in a way that partly favours smaller operations.

Pre-market licensing, site licensing and GMP set a floor everyone has to clear. A small brand can't skip them, and a large brand can't buy its way past them. Both are operating under the same framework.

That's a meaningfully different situation from the US market, where a small operation can put a product on shelves without pre-market authorisation. See supplements regulation in Canada.

What to actually evaluate

Not company size. The specifics, which are checkable either way:

• Is the medicinal ingredient quantified per dose, not hidden in a blend?
• Is there an NPN, verifiable in Health Canada's database?
• Do the marketing claims stay inside what the monograph authorises?
• Can the manufacturer produce finished-product testing near end of shelf life?
• Do they answer specific questions specifically?

A large company can pass all five. Plenty of small ones fail them. We'd rather compete on those answers than on being the underdog.

General information about a natural health product, not medical advice.